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SUMMARY
Central venous catheters are of an essential importance to critically ill patients who require long-term 
venous access for various purposes. Their use made the treatment much easier, but still they are not 
harmless and are prone to numerous complications. Catheter infections represent the most significant 
complication in their use.   The frequency of infections varies in different patient care settings, but their 
appearance mostly depends on the patient’s health condition, catheter insertion time, localization of the 
catheter and type of the used catheter. Since they are one of the leading causes of nosocomial infections 
and related to significant number of morbidity and mortality in intensive care units, it is very important 
that maximal aseptic precautions are taken during the insertion and the maintenance period. Prevention 
of infection of the central venous catheters demands several measures that should be applied routinely.
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INTRODUCTION
Central venous catheters (CVC) are used in 
critically ill patients around the world and are 
essential in the treatment of infants and adults 
requiring hemodynamic monitoring, hemodi-
alysis, tissue and organ transplantation, admin-
istration of liquids, blood products, chemother-
apy, antibiotics and parenteral nutrition [1-5]. 
Infections are the most common complications 
that develop in the use of CVC [6, 7]. Incidence 
of infections varies with the patient’s health sta-
tus, duration of insertion time and localization, 
as well as with the type of catheter and asepsis 
precautions [8].
In US, more than 5 million patients require 
prolonged central venous access. Even though 
it is often avoidable, the risk of infection is very 
high and in US it ranges between 80.000 cases 
annually [7]. CVC infection-related mortal-
ity and morbidity rates are not negligible and 
range from 0% to 35%. It is certain that these 
infections are the cause of prolonged stay in 
hospitals and increased medical care costs [7, 
9, 10]. It is estimated that additional costs of 
medical care due to bloodstream infections 
vary between 34.000 to 56.000 USD [11].
TYPES OF INFECTIONS ASSOCIATED WITH 
THE CENTRAL VENOUS CATHETERS
Infections associated with the CVC are mani-
fested as local and systemic infections.
Local infections developed around the in-
sertion site are often manifested by erythema, 
edema, and purulent exudate in diameter of 2 
cm, with or without the bloodstream infection 
and pus [8]. This should be distinguished from 
the clear exudates, which commonly occur af-
ter catheter insertion. They may also involve 
thrombophlebitis within the cannulated blood 
vessel or subcutaneous sepsis, which are asso-
ciated with tunneled devices [12] or as tunnel 
infection in the form of erythema, induration 
or pain in diameter of 2 cm from the exit place 
of the catheter and along the tunnel projection, 
with or without the Catheter Related Blood 
Stream Infection (CRBSI) [8]. Cellulitis can 
occasionally spread from the catheter exit site, 
particularly in Streptococcus pyogenes or Sta-
phylococcus aureus infections. Colonization of 
the central venous catheter implies the growth 
of more than 15 bacterial colonies (semi-quan-
titative method) in the absence of other clinical 
signs of infection [1, 12].
Patients with systemic manifestation of 
CVC-related infection can develop pyrexia of 
38oC without any other clear signs of infection. 
Transient pyrexia or rigor can develop during 
the regular flushing of the catheter [12]. Cath-
eter Related Blood Stream Infection (CRBSI) is 
either a bacteremia or fungemia documented 
with at least one peripherally obtained blood 
culture, which can lead to the development of 
sepsis. Sepsis is one of the most complex chal-
lenges in the treatment of critically ill patients, 
despite implementation of new resuscitating 
protocols. Definition of catheter associated 
bloodstream infections (CABI) is less strict and 
it implies the presence of vascular catheter as 
a solitary cause in patients who either have an 
indwelling catheter or have had one within 48 
hours of the positive blood culture [11, 13, 14].
ORIGIN OF THE MICROORGANISMS 
CAUSING THE CENTRAL VENOUS 
CATHETER RELATED INFECTIONS
The most common etiological factors are the 
conditions under which CVC is inserted, ex-  
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perience of the operator, choice of the place for insertion, 
care of the catheter and many more. There are five different 
ways that microorganisms use to reach the tip of the CVC 
and cause the consequent CRBSI [11].
1. Extra luminal: The most common infection of the 
short-term catheters in the Intensive Care Unit (ICU) is 
caused by the migration of the microorganisms from the 
patient’s skin micro flora from the outer side of the cath-
eter up to its tip and finally to the bloodstream [6, 8]. This 
source of infection is primarily related to the inability of 
skin antiseptics to sterilize the skin at the site of catheter 
insertion. Once the catheter is colonized it becomes a per-
manent cause of bacteremia [12].
2. Intra luminal: It has been proven that microorgan-
isms colonize the inner components of the catheter hub 
and its luer connector via intraluminal migration from 
infusates [12]. This is considered the most common way 
of infection of long-term CVCs.
3. Hematogenous: Dissemination of microorganisms 
through the blood from distant sites can result in coloniza-
tion of the catheter. This is a less common way of infection 
[12], which predominantly depends on the catheter mate-
rial and antibiotic coating.
4. Contamination through medicaments and infusion: 
Infusates may be contaminated during manufacturing or 
manipulation with sets for intravenous infusion or even 
during the preparation of fluids for injection. This way of 
contamination is very rear in the USA but may occur in 
developing countries [11].
5. Impaction during insertion: Frequently neglected 
way of infection. It occurs by entering of bacteria from 
the patient’s skin to the catheter hub during the placement 
of catheter and is a direct indicator of inadequate asepsis 
of the skin prior to insertion.
When microorganisms reach the surface of the catheter 
they directly bind to the polymers on its outer surface and 
form a biofilm called glycocalyx which consists of various 
polysaccharides. The biofilm protects the microorgan-
isms from the effect of neutrophils and antibiotics and 
thus makes these infections very difficult to treat. During 
the insertion of catheter, a large number of platelets and 
proteins gets attached to its surface, and in a period of 3 
hours forms a layer consisting mainly of fibronectin, which 
may later on represent a potential binding place for micro-
organisms, especially Staphylococcus [7, 12].
Most of the microorganisms causing catheter infection 
originate from the patient’s own microflora. Gram-positive 
cocci, including the Staphylococcus aureus and coagulase-
negative Staphylococcus – such as Staphylococcus epider-
midis are the leading cause of infections associated with 
catheters [1, 7, 11]. Infections caused by gram negative 
bacillus and most commonly the coli form bacteria (En-
terobakteriaceae) are usually found in highly risk units like 
the ICU. Infections with coli form bacteria are common in 
patients with tracheostomy on mechanical ventilation [12].
Candida species has become a significant pathogen in 
the ICUs, especially in patients on total parenteral nutri-
tion (TPN) and patients on corticosteroid and other im-
munosuppressive therapy [3, 7, 11, 12].
Infections of the catheter in pediatric patients are caused 
by the similar spectrum of microorganisms. Most common 
is coagulase-negative Staphylococcus in 20%-50%. Gram-
negative bacteria cause 25% of nosocomial infections and 
Staphylococcus aureus and Candida spp. are responsible for 
about 10% of these infections. Other microorganisms vary 
in relation to patient’s age, so β Hemolytic Streptococcus has 
larger prevalence in neonatal population and accounts for 
8.5%, Enterococcus has bimodal peak so it is most com-
mon in neonatal population and in patients of 13-65 years, 
with frequency of 8.5–9.4%. Klebsiella spp. makes 7.5% of 
CVC-related infections in pediatric patients and together 
with coagulase-negative staphylococcus and Staphylococ-
cus aureus it is on the third place of causes of CVC-related 
infections in pediatric population (Table 1) [11].
CLINICAL AND BACTERIOLOGICAL DIAGNOSIS AND 
TREATMENT OF THE CENTRAL VENOUS CATHETER 
RELATED INFECTIONS
The basis for making diagnose of CRBSI is an identifi-
cation of the microorganism from the tip of the catheter 
and from the blood. Accordingly, definite diagnosis usually 
means that the catheter must be extracted. The diagnosis 
or high degree of suspicion on CRBSI must lead to ur-
gent reaction in order to avoid complications of persistent 
bacteremia such as septic shock, endocarditis or septic 
metastasis [8].
Clinical manifestations typical for CRBSI are unspecific, 
and they can manifest with high temperature, rigor and 
shivering. Because of relatively low specificity, catheter 
should not be removed only because of the presence of 
high temperature. Pus and inflammation signs on the out-
put of the catheter and positive hemoculture have a higher 
specificity but no sensibility, which is why the extraction 
of catheter in such cases should be recommended only for 
clinically well-justified doubt on CRBSI.
CV-related infection most possibly occurs when the 
hemocultures are positive for common causes of nosoco-
mial infection, such as coagulase-negative Staphylococcus, 
Staphylococcus aureus and Candida spp. [11]. If the catheter 
was tunneled, tunnel infection would develop which might 
affect a wide area of the anterior chest wall, especially in 
patients with neutropenia and in immunocompromised 
patients. In the ICU patients, CRBSI can manifest as inex-
plicable hypotension, tachycardia and metabolic acidosis.
A diagnostic procedure that includes blood sampling 
for bacterial culture should be applied only when there 
is an adequate clinical doubt on CRBSI. If there is such 
doubt, two sets of samples are taken for the culture [7, 15].   
Table 1. Most common bacteria in CVC infections in pediatric patients
Bacteria Frequency (%)
Coagulase-negative Staphylococcus 20–50
Staphylococcus aureus 10
Candida species 10
Enterococcus 8.5–9.4
Klebsiella spp 7.5     
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Hemoculture taken by aspiration from the catheter is 
more commonly associated with false positive results and 
because of that it is important that one peripheral blood 
sample is taken. For the confirmation of CRBSI, micro-
biological profile of the sample taken from the lumen of 
the catheter should be the same with the hemoculture ob-
tained from the peripheral veins. Colonies obtained from 
the CVC should be 5 times numerous than those obtained 
from the peripheral veins and antibiogram taken from the 
CVC should be positive two hours before the result of the 
sample from the peripheral veins [11, 16].
Routine extraction of the suspicious catheter results in 
the loss of a large number of “innocent” catheters which 
could have been saved. Catheters should always be extract-
ed if there were clear signs of venous thrombosis, if septic 
shock was developing or if pus appeared around the site of 
catheter insertion. Saving of the catheter depends on the 
localization of the infection, cause of infection, and the 
immune status of the host. Short-term catheters are usually 
extracted, while long-term catheters should be considered 
for treatment. Infections of the tunnel or port demand ex-
traction because the mechanism of infection includes the 
creating of biofilm around the internal surface that cannot 
be efficiently treated with antibiotics.
Fungal infections cannot be treated successfully in this 
way. In order to prevent the development of sepsis, sys-
tematic antifungal therapy is necessary for the infection 
with Candida spp. Because of the small number of success-
fully cured fungal CRBSI (30%) and the direct increase of 
morbidity, it is recommended that the catheter should be 
removed as soon as fungal infection is diagnosed. Assump-
tion that the catheter is the source of fungal infection is 
supported by the isolated Candida Parapsilosis, moreover 
if the patient is on parenteral nutrition. The ratio of culture 
taken from the suspiciously infected catheter in compari-
son to the one taken from the skin should be 5:1, confirma-
tion of the cause is two blood samples taken more than 2 
hours apart, or if the patient has neutropenia without other 
clear causes of infection [8, 17].
In patients without persistent infection of the blood-
stream and with positive culture on coagulase-negative 
Staphylococcus, but without local or metastatic infective 
complications, the catheter should not necessarily be re-
moved and antibiotic therapy should be applied [11]. Data 
collected from several studies showed that Staphylococcus 
Aureus infection was the most common (⅔ CRBSI), during 
the first two weeks after the catheter was inserted. This re-
sulted in studies wherein prophylactic vancomycin therapy 
was applied in duration of 10-14 days. For milder forms of 
infection, vancomycin solution 100-1000 times more con-
centrated compared to the standard dosage for parenteral 
usage was placed in the lumen of the catheter, and then the 
catheter was closed for 12 hours. However, this method is 
not recommended for routine use, while the prophylactic 
use of vancomycin lock solution of 25 μg/mL represents 
the unique factor of risk of the vancomycin resistant Ente-
rococcus infection [7, 18].
If, however, it was decided that the catheter should be 
removed, the tip of the catheter should be sent for the 
microbiological analysis. Surface of the skin around the 
place of the catheter’s extraction must be adequately dis-
infected, catheter is removed with pean, the tip is then 
placed in a sterile test tube, and sent for bacteriological 
analysis. For patients with mild and moderate signs of in-
fection suspected for possible CVC-related infection, the 
replacement of the catheter may be an option while waiting 
for the microbiological results taken from the tip of the 
catheter. If the result from the tip was positive for bacteria, 
the newly placed catheter would be removed and placed 
on some other position. The catheter exchange through a 
guide wire reduces mechanical risks of placing the catheter 
in an unwanted place, but does not eliminate the risk of 
infection. In case of persistent bacteremia when there is no 
clinical improvement in 3 days after the removal, there is a 
possibility of infective endocarditis, septic thrombosis or 
the infection expansion to distant places [11].
RISK FACTORS AND PREVENTION OF 
DEVELOPMENT OF THE CENTRAL VENOUS 
CATHETER INFECTION
Logical approach to prevention of infections associated 
with CVC is an observation of this problem through two 
aspects: the aspect of the catheter and the aspect of the 
medical staff.
The catheter
The risk of CRBSI is much higher for CVCs than for pe-
ripheral vein cannulas and Swan-Ganz catheters [12]. One 
of the main reasons is that CVCs, especially those used for 
parenteral nutrition, reside in the blood vessel for longer 
time, which is in hospital conditions the most significant 
factor of risk of CVC-related infection [7].
The material, from which the catheter is made of, has 
high effect on development of CRBSI. It is very important 
that the catheter is biocompatible, hemocompatible, bi-
ostable, chemically neutral and inert to the influence of 
other medicaments. It must be flexible but at the same 
time resistant, X-ray opaque, with a thin wall resistant to 
sterilization and with a safe lock system. From all avail-
able catheters on market, the CVC made of Teflon and 
polyurethane has proved to be the safest in terms of com-
plications resulting from the infections, whereas the cath-
eters made of polyethylene and polyvinyl chloride have 
been withdrawn from the market due to their numerous   
disadvantages.
When considering infections associated with CVC, the 
circumstances under which the catheter is inserted can-
not be ignored. Urgent catheter placement carries a much 
higher risk of CVC-related infection, and these catheters 
must be replaced as soon as the general condition of the 
patient is stabilized [19].
The requirements of every individual patient will de-
termine the type of catheter, but for the administration of 
parenteral nutrition and other solutions containing lipids,   
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there should always be a separate lumen that will be used 
only for this purpose [20].
Catheters coated with antibiotics, working preventively 
in relation to adhesion and colonization of microorgan-
isms, have been developed. Most commonly used and 
tested catheters impregnated with antibiotics are: 
•   Catheters coated with Minocycline/rifampin: Efficien-
cy of these catheters in prevention of infections has 
been confirmed in many studies; it has been proven 
that they are associated with a small degree of colo-
nization and incidence of CVC-related infection. The 
comparison of catheters coated with Minocycline/
rifampin and those coated with Chlorhexidine-Silver 
Sulfadiazine has confirmed that the former ones are 
three times more efficient in their protective function 
[21]. These catheters keep their antimicrobial feature 
for 2 weeks after the insertion, and their use is cost-
effective if they are used for more than one week [22].
•   Catheters coated with Chlorhexidine-Silver Sulfadi-
azine: the catheters coated with these substances, both 
externally and internally are currently available. Anti-
septics are released from its surface for the period of 
15 days after the insertion, which makes them effective 
in the struggle against the colonization of bacteria and 
infections associated with CVC. So far, there have been 
no data on development of resistance of any of these 
substances, but there have been some case reports in 
Japan and UK on anaphylactic reactions that had ap-
peared after the insertion of these catheters [7, 23]. 
This is a very rare side effect but it certainly must be 
taken in consideration. It is advised for catheters coat-
ed with Minocycline/Rifampin and Chlorhexidine-
Silver Sulfadiazine to be used when there is a need for 
them from 1 to 3 weeks as well as in case of higher risk 
of infection [24]. 
•   Silver-platinum and carbon catheters: This type of 
coating is relatively new, and together with Minocy-
cline-rifampin and Chlorhexidine-Silver Sulfadiazine 
catheters, represents an equally good instrument for 
the prevention of colonization and development of 
CVC-related infection when the central venous ac-
cess is needed for more than 5 days. 
•   5-fluorouracil: catheters coated with this substance 
are also new generation catheters and are very ef-
ficient in prevention of infections associated with 
catheters; these catheters are even more efficient than 
those impregnated with the Chlorhexidine-Silver Sul-
fadiazine [25]. 
Numerous studies have proved that the use of antico-
agulant medication reduces the incidence of thrombosis of 
catheter and consequential CRBSI. This approach reduces 
the amount of deposited fibronectin on the surface of the 
catheter which may later on favor the adhesion of staphy-
lococcus [7, 12].
Insertion of CVC in the femoral vein is associated with 
higher risk of infection than the insertion in the internal 
jugular vein, and the insertion into the subclavian vein 
carries the lowest risk of infection. From the aspect of the 
infection control, subclavian vein is the place where the 
catheter should be inserted, but when choosing the right 
place for insertion of CVC, mechanical complications, sub-
clavian vein stenosis and the experience of the operator 
must be taken into consideration. One study has shown 
that the colonization, in case of the internal jugular vein 
is increased with the body mass index (BMI) lower than 
24.2 and in case of the femoral vein with BMI higher than 
28.4. In case of the catheter insertion in the contraindi-
cated subclavian route, the patient’s BMI and the risk of 
thrombophlebitis, which is higher for femoral vein, have 
a great effect [7, 26].
There is different percentage of aqueous and alcoholic 
solutions of chlorhexidine and povidone iodine available 
on the market. The disinfection of the CVC insertion site 
with 2% alcohol chlorhexidine lessens the risk of infection 
by 50% compared to 10% povidone iodine and 70% alcohol 
and is crucially important for the prevention of CVC infec-
tion. The solution of 2% chlorhexidine with 70% alcohol is 
very efficient in the elimination of the biofilm and proteins 
from the tip of the catheter [7, 25]. Even today, this solu-
tion is recommended as useful for disinfection [27, 28].
Two most common instruments for the coverage of the 
insertion site are transparent sticking plaster and standard 
gauze and plaster. Transparent plaster has many advantages 
when compared to conventional bandages because it gives 
the clear view on the condition of the skin around the cath-
eter and consequently contributes to prompt recognition 
of possible local complications. It also helps the patient 
keep his/her personal hygiene by showering, demands less 
frequent replacement and saves time for medical staff. 
Despite the abovementioned advantages, the use of 
standard gauze is recommended in cases of heavy bleed-
ing [7, 12]. 
The use of ultrasound during the placement of CVC is 
considered the method of choice for the reduction of inci-
dence of CVC infections, but only in cases when operator 
has an adequate experience in placement of catheter using 
this method [7]. 
Medical staff
Experience of operator, and the time and technique of in-
sertion have effect on the risk of infection of CVC. During 
the insertion, optimal conditions of asepsis should be pro-
vided by routine use of sterile gloves, compresses, masks, 
caps and medical coats. Best way to insert catheter is using 
the Seldinger technique [7].
Blood, blood products and lipid emulsions increase 
the infection incidence of CVC, which is why the routine 
replacement of all catheter connectors, systems and exten-
sions of CVC for infusion immediately or in the first 24 
hours after the administration of one of the abovemen-
tioned solutions is recommended. Before any manipula-
tion with the catheter, one’s hands should be cleaned with 
alcohol or disinfectant. External parts of the catheter are 
treated before every use with antiseptic solutions based on 
chlorhexidine. Application of antibiotic ointments around 
the catheter exit has been proven to be inefficient in the 
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attempt to prevent CVC infection, therefore its use is not 
recommended. It has been confirmed that antibiotic coat-
ing helps the development of resistance to local microor-
ganisms [7, 12].
The programs of education for young doctors on the 
CVC insertion in the ICU and training of nurses and 
technicians about the proper care of the catheters and an 
optimal number of medical staff for the care of a single 
patient significantly contribute to reduction of CVC infec-
tions [7, 29, 30].
CONCLUSION AND RECOMMENDATIONS
Central venous catheters are of an essential importance in 
the therapeutic approach to a critically ill patient. Infec-
tions of the catheter are very serious and very common 
complications in the establishment of the venous route 
and the leading cause of nosocomial infections in the ICU 
[13]. Prevention of CVC infection implies several methods 
that should be the routine. Most important are the imple-
mentation of well-defined protocols about the placement 
and care of CVC, and the education of doctors and other 
medical staff about proper handling with the equipment. 
During the insertion and care of CVC, the most important 
rules of asepsis and antisepsis must be respected, related 
primarily to disinfection of the insertion site with 2% 
chlorhexidine solution, disinfection of operator’s hands, 
and the use of sterile gloves and compresses. Choice of the 
vein for the elective placement of CVC is the subclavian 
vein whenever possible. If there was an increased risk of 
infection, catheter coated with antibiotics would be recom-
mended. Prophylactic use of antibiotics should be avoided 
along with the use of antibiotic cream around the place 
of catheter exit site. Transparent hydro permeable plas-
ters should be used and replaced more often than every 
7 days. Catheters should not be changed unless indicated 
and should be withdrawn only when they are no longer 
needed. Always consider enteral nutrition and peripheral 
veins prior to the use of CVCs [7, 12].
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КРАТАК САДРЖАЈ
Цен  трал  ни вен  ски ка  те  те  ри су од пре  суд  ног зна  ча  ја за бо  ле-
сни  ка ко  ји  ма је по  тре  бан ду  го  тра  јан и без  бе  дан вен  ски при-
ступ у раз  ли  чи  те свр  хе. Иако је њи  хо  ва упо  тре  ба до  при  не  ла 
уна  пре  ђе  њу ле  че  ња кри  тич  но обо  ле  лих осо  ба, она је по  ве-
за  на с ве  ли  ким бро  јем мо  гу  ћих ком  пли  ка  ци  ја. Уче  ста  лост 
ин  фек  ци  ја за  ви  си од усло  ва ле  че  ња, здрав  стве  ног ста  ња 
бо  ле  сни  ка, тра  ја  ња по  ста  вља  ња ка  те  те  ра, ње  го  ве ло  ка  ли-
за  ци  је и вр  сте. С об  зи  ром на то да су ин  фек  ци  је цен  трал-
них вен  ских ка  те  те  ра во  де  ћи узрок бол  нич  ких ин  фек  ци  ја и 
узрок мор  би  ди  те  та и мор  та  ли  те  та у је  ди  ни  ца  ма ин  тен  зив  не 
не  ге, ве  о  ма је ва  жно во  ди  ти ра  чу  на о мак  си  мал  ној асеп  си 
при  ли  ком њи  хо  вог пла  си  ра  ња и одр  жа  ва  ња. Пре  вен  ци  ја 
ин  фек  ци  ја ко  је су по  ве  за  не са цен  трал  ним вен  ским ка  те  те-
ри  ма под  ра  зу  ме  ва не  ко  ли  ко ме  ра ко  је је по  треб  но ру  тин-
ски при  ме  њи  ва  ти.
Кључ  не ре  чи: за  ра  зна обо  ље  ња; цен  трал  ни вен  ски ка  те  те-
ри; ин  фек  ци  је по  ве  за  не са цен  трал  ним вен  ским ка  те  те  ри  ма
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